<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Cardiology Product Guide &#187; HeartMate II</title>
	<atom:link href="http://blog.cardiologyproductguide.com/tag/heartmate-ii/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.cardiologyproductguide.com</link>
	<description>A comprehensive guide to cardiology products for medical professionals </description>
	<lastBuildDate>Tue, 14 Jun 2011 11:39:11 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>FDA Approves For Permanent Treatment Of Advanced Heart Failure Assist Device Pioneered By Texas Heart Institute At St. Luke&#8217;s Episcopal Hospital</title>
		<link>http://blog.cardiologyproductguide.com/2010/01/26/fda-approves-for-permanent-treatment-of-advanced-heart-failure-assist-device-pioneered-by-texas-heart-institute-at-st-lukes-episcopal-hospital/</link>
		<comments>http://blog.cardiologyproductguide.com/2010/01/26/fda-approves-for-permanent-treatment-of-advanced-heart-failure-assist-device-pioneered-by-texas-heart-institute-at-st-lukes-episcopal-hospital/#comments</comments>
		<pubDate>Tue, 26 Jan 2010 05:18:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Devices]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[federal Food and Drug Administration]]></category>
		<category><![CDATA[HeartMate II]]></category>
		<category><![CDATA[St. Luke's Episcopal Hospital]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/?p=227</guid>
		<description><![CDATA[The federal Food and Drug Administration has approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke&#8217;s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure. The approval of the pump device, the HeartMate II, follows several years of clinical trials and is seen as a [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://blog.cardiologyproductguide.com/files/2010/01/St.-Lukes-Episcopal-Hospital.png"><img class="alignright size-full wp-image-228" style="margin: 5px" src="http://blog.cardiologyproductguide.com/files/2010/01/St.-Lukes-Episcopal-Hospital.png" border="0" alt="St. Luke's Episcopal Hospital" width="200" height="71" /></a>The federal Food and Drug Administration has approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke&#8217;s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure. The approval of the pump device, the HeartMate II, follows several years of clinical trials and is seen as a major milestone for patients in the United   States.</p>
<p>For the full story, <a href="http://www.medicalnewstoday.com/articles/176869.php" target="_self">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2010/01/26/fda-approves-for-permanent-treatment-of-advanced-heart-failure-assist-device-pioneered-by-texas-heart-institute-at-st-lukes-episcopal-hospital/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thoratec HeartMate II gets FDA nod</title>
		<link>http://blog.cardiologyproductguide.com/2008/04/24/thoratec-heartmate-ii-gets-fda-nod/</link>
		<comments>http://blog.cardiologyproductguide.com/2008/04/24/thoratec-heartmate-ii-gets-fda-nod/#comments</comments>
		<pubDate>Thu, 24 Apr 2008 18:42:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[bridge-to-transplantation]]></category>
		<category><![CDATA[BTT]]></category>
		<category><![CDATA[HeartMate II]]></category>
		<category><![CDATA[Left Ventricular Assist System]]></category>
		<category><![CDATA[LVAS]]></category>
		<category><![CDATA[PMA]]></category>
		<category><![CDATA[Thoratec]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/2008/04/24/thoratec-heartmate-ii-gets-fda-nod/</guid>
		<description><![CDATA[Thoratec Corporation has received FDA approval for its PMA (PreMarket Approval) application, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure. The system supports the weakened heart of younger adults who are at risk of dying while awaiting a heart transplant.]]></description>
			<content:encoded><![CDATA[<p><img border="0" vspace="5" align="left" width="165" src="http://blog.cardiologyproductguide.com/files/2008/04/thoratec-logo.gif" hspace="5" alt="Thoratec Logo" height="60" /><a href="http://www.thoratec.com/">Thoratec Corporation </a>has received FDA approval for its PMA (PreMarket Approval) application, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure. The system supports the weakened heart of younger adults who are at risk of dying while awaiting a heart transplant.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2008/04/24/thoratec-heartmate-ii-gets-fda-nod/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

